ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Futurography Newsletter: Synthetic Biology and the Space Race – Slate Magazine (blog)

Continue reading

2017-04-06 Michael Zand NEWS

Can Stem Cell ‘Patch’ Help Heart Failure? – WebMD


Slate Magazine (blog)

Futurography Newsletter: Synthetic Biology and the Space Race
Slate Magazine (blog)
This month, Futurography is focusing on synthetic biology, an emerging field that draws on engineering and computer science principles to reshape the basic stuff of life itself. It’s our final course for the current academic year, and we’re excited to …

Continue reading

2017-04-06 Michael Zand NEWS

Health Highlights: April 6, 2017 – U.S. News & World Report


Medical News Today

Can Stem Cell ‘Patch’ Help Heart Failure?
WebMD
WEDNESDAY, April 5, 2017 (HealthDay News) — Scientists report another step in the use of stem cells to help treat people with debilitating heart failure. In an early study of 27 patients, Japanese researchers used patients’ own muscle stem cells to …
Treating heart failure with muscle stem cell patchMedical News Today
NHLBI stem cell consortium provides new insights into genetics of heart disease, other conditionsNational Institutes of Health (press release)
AI predicts the layout of human stem cellsEngadget
EurekAlert (press release) –Nature.com –The San Diego Union-Tribune
all 61 news articles »
Continue reading

2017-04-06 Michael Zand NEWS

Stem cell drug screen yields potential alternative to statins – EurekAlert (press release)

EurekAlert (press release)Stem cell drug screen yields potential alternative to statinsEurekAlert (press release)In a study appearing in the April 6, 2017 issue of Cell Stem Cell, cardiac glycosides reduced levels of a precursor of LDL in liver-like ce… Continue reading

2017-04-06 Michael Zand NEWS

Chemotherapy Following Immunotherapy in Bladder Cancer – OncLive

OncLiveChemotherapy Following Immunotherapy in Bladder CancerOncLivePanelists: Daniel P. Petrylak, MD, Yale University Cancer Center; Dean F. Bajorin, MD, Memorial Sloan Kettering Cancer Center; Robert Dreicer, MD, MS, Virginia Cancer Center; Arjun V. … Continue reading

2017-04-06 Michael Zand NEWS

NHLBI stem cell consortium provides new insights into genetics of heart disease, other conditions – National Institutes of Health (press release)

National Institutes of Health (press release)NHLBI stem cell consortium provides new insights into genetics of heart disease, other conditionsNational Institutes of Health (press release)A group of NIH-funded scientists has published the first studies … Continue reading

2017-04-06 Michael Zand NEWS

CAR T-Cell Tx Durability May Depend on B-ALL Disease Burden – MedPage Today

CAR T-Cell Tx Durability May Depend on B-ALL Disease BurdenMedPage TodayWASHINGTON — CD19-specific chimeric antigen receptor (CAR) T-cell therapy was more likely to be definitive and curative — rather than just a bridge to stem cell transplant — whe… Continue reading

2017-04-06 Michael Zand NEWS

Nanoparticle-delivered combo boosts cancer immunotherapy – FierceBiotech

Health Highlights: April 6, 2017
U.S. News & World Report
A stem cell treatment for autism shows promise, according to a new study, but the investigators and other experts emphasize that the therapy is still in the early stages and much more research is needed. The Duke University study included 25 children …

and more »

Continue reading

2017-04-06 Michael Zand NEWS
  • 1
  • …
  • 1,875
  • 1,876
  • 1,877
  • 1,878
  • 1,879
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

FierceBiotech

Nanoparticle-delivered combo boosts cancer immunotherapy
FierceBiotech
Now University of North Carolina researchers have found that using nanoparticles can boost the efficacy of cancer immunotherapy treatments. Senior author Andrew Wang, M.D., likens checkpoint proteins to red traffic lights—they send signals to the …